Skip to Content Skip to Content

Coronavirus

A look at what didn't happen this week
Philadelphia Inquirer

A look at what didn't happen this week

Kevin J. Downes of the Perelman School of Medicine debunked a myth claiming that COVID-19 vaccines are linked to strokes in children. “None of the mRNA vaccines that are under investigation for children are associated with that,” he said.

Debate: Should we waive COVID-19 vaccine patents for low-income countries?
Philadelphia Inquirer

Debate: Should we waive COVID-19 vaccine patents for low-income countries?

Harsha Thirumurthy of the Perelman School of Medicine argued that we should waive COVID-19 vaccine patents for low-income countries. “We simply can’t bring an end to the pandemic—here in the U.S. or elsewhere—without rapidly closing the global vaccine gap,” he wrote. “And we can’t close that gap without waivers of patent protections that are keeping lower-income countries from manufacturing vaccines themselves.”

With more kids eligible for vaccines, is the pandemic in a new phase?
Child wearing mask in school writes at a desk

With more kids eligible for vaccines, is the pandemic in a new phase?

With the FDA authorization last week, 28 million more children are eligible to be vaccinated against COVID-19. Experts from the School of Nursing and Perelman School of Medicine share their thoughts about what to expect in the weeks and months to come.

Katherine Unger Baillie

The controversy surrounding vaccinations, then and now
Person in a white coat reaching into a refrigerator full of bagged vaccines.

Image: Dan Burke

The controversy surrounding vaccinations, then and now

Robert Aronowitz, Walter H. and Leonore C. Annenberg Professor in the Social Sciences, reflects on vaccine hesitancy today compared to the past, and the politicization of public health.

From Omnia

Has the virus infected huge numbers of younger children?
The New York Times

Has the virus infected huge numbers of younger children?

Scott Hensley of the Perelman School of Medicine said the COVID-19 vaccines will strengthen children’s protection against the virus and its future variants, even if they’ve already contracted and recovered from COVID-19.

COVID now a ‘major cause of death’ in kids but many parents remain hesitant on vaccine
Newsweek

COVID now a ‘major cause of death’ in kids but many parents remain hesitant on vaccine

Researchers co-led by Kathleen Hall Jamieson of the Annenberg Public Policy Center found that full FDA approval will help convince parents to get their children vaccinated against COVID-19. “As more evidence of children getting vaccinated appears, people will feel more comfortable,” Jamieson said.

Why cash incentives and lotteries for COVID-19 vaccinations failed
Quartz

Why cash incentives and lotteries for COVID-19 vaccinations failed

Alison Buttenheim of the School of Nursing said if policy makers had studied what does and doesn’t motivate people to get vaccinated, they would have probably rolled out COVID-19 vaccine mandates sooner.

Do COVID-19 vaccine incentives work?
Marketplace (NPR)

Do COVID-19 vaccine incentives work?

Kevin Volpp of the Perelman School of Medicine said he is interested to know how this year’s vaccine-incentive programs will impact COVID-19 booster rates now. “People might learn that if you wait you’ll get an incentive next time,” he said.

Four facts about the COVID-19 boosters
Stock image of two vials of COVID-19 vaccines. One is upright, the other laying on its side. They both say "COVID-19 vaccine, LOT: D66A443, EXP: 03.22, INJECTION ONLY"

Four facts about the COVID-19 boosters

The FDA and CDC endorsed boosters of the Moderna and Johnson & Johnson COVID-19 vaccines just a month after the agencies did the same for a Pfizer/BioNTech booster. Here’s what’s known today about these shots.

Michele W. Berger

Americans wonder: Which COVID-19 booster is best?
Reuters

Americans wonder: Which COVID-19 booster is best?

Paul Offit of the Perelman School of Medicine said COVID-19 booster shots are most important for older adults who got the Pfizer/BioNTech vaccines.